Market Research Report
Global Infectious Disease Diagnostics Market - Study of COVID-19 Impact (Impact Categorized by Product Type, Disease Type, End-User, and Region) - Size, Share, and Predictions from 2021-2027
|Published by||AnalystView Market Insights||Product code||999605|
|Published||Content info||302 Pages
Delivery time: 2-3 business days
|Global Infectious Disease Diagnostics Market - Study of COVID-19 Impact (Impact Categorized by Product Type, Disease Type, End-User, and Region) - Size, Share, and Predictions from 2021-2027|
|Published: April 1, 2021||Content info: 302 Pages||
By 2020, the value of the global Infectious Disease Diagnostics market was estimated at USD 18.3 Billion, with a growth of 6.2% CAGR during the estimated timeframe, 2021-2027.
The epidemiological weight of contagious diseases like severe acute respiratory syndrome, Chikungunya, Ebola, Coronavirus, Swine flu, Avian flu, and Zika has presented an opportunity for their early determination & prevention. Similarly, the outbreak of the COVID-19 pandemic has excessively increased the request for various POC diagnostic kits for quick diagnosis and control of the spread of coronavirus. The increasing awareness for early detection, increase in funding for research on infectious disease diagnostics, and change in focus from centralized laboratories to decentralized point-of-care testing services are anticipated to drive the growth of the market. The growing burden of transmissible diseases and hospital-acquired infections (HAIs) worldwide has boosted the infectious disease diagnostics therapeutics demand. The recent outbreak of the coronavirus disease (COVID-19), which emerged in November 2019 in Wuhan, China has created destruction in several countries across the world.
Some significant factors such as heavy growth in funding for research on infectious disease diagnostics, the rising global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing are encouraging the growth of the Infectious Disease Diagnostics Market. Furthermore, factors such as advancements in sequencing technologies, increasing application of molecular diagnostic technologies in pharmacogenetics, growing awareness, and acceptance of personalized medicine, point-of-care testing are expected to drive the market growth over the forecast period.
The scope of this report encompasses the market by its most significant segments, which include the following: